Aurora Cannabis Inc. (ACB.TO)
CAD 6.11
(-4.83%)
CAD 6.11
(-4.83%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 270.28 Million CAD | 16.71% |
| 2022 | 231.58 Million CAD | 4.63% |
| 2021 | 221.33 Million CAD | -9.75% |
| 2020 | 245.25 Million CAD | -12.07% |
| 2019 | 278.9 Million CAD | 12.49% |
| 2018 | 247.93 Million CAD | 349.2% |
| 2017 | 55.19 Million CAD | 205.51% |
| 2016 | 18.06 Million CAD | 1155.29% |
| 2015 | 1.43 Million CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | -100.0% |
| 2008 | 40.83 Thousand CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q3 | 67.41 Million CAD | 4.64% |
| 2023 Q1 | 63.41 Million CAD | -15.57% |
| 2023 FY | 270.28 Million CAD | 16.71% |
| 2023 Q2 | 64.41 Million CAD | 1.58% |
| 2022 FY | 231.58 Million CAD | 4.63% |
| 2022 Q4 | 75.11 Million CAD | 4.13% |
| 2022 Q2 | 61.67 Million CAD | 25.2% |
| 2022 Q1 | 49.26 Million CAD | -1.9% |
| 2022 Q3 | 72.13 Million CAD | 16.95% |
| 2021 Q4 | 50.21 Million CAD | -0.43% |
| 2021 Q3 | 50.43 Million CAD | -16.76% |
| 2021 Q1 | 60.1 Million CAD | 10.08% |
| 2021 Q2 | 60.58 Million CAD | 0.8% |
| 2021 FY | 221.33 Million CAD | -9.75% |
| 2020 Q1 | 67.81 Million CAD | -5.97% |
| 2020 Q2 | 67.67 Million CAD | -0.2% |
| 2020 Q3 | 55.16 Million CAD | -18.49% |
| 2020 Q4 | 54.6 Million CAD | -1.01% |
| 2020 FY | 245.25 Million CAD | -12.07% |
| 2019 FY | 278.9 Million CAD | 12.49% |
| 2019 Q4 | 72.11 Million CAD | -4.51% |
| 2019 Q3 | 75.52 Million CAD | 34.79% |
| 2019 Q2 | 56.02 Million CAD | -25.54% |
| 2019 Q1 | 75.24 Million CAD | -23.95% |
| 2018 Q4 | 98.94 Million CAD | 51.88% |
| 2018 FY | 247.93 Million CAD | 349.2% |
| 2018 Q3 | 65.14 Million CAD | 20.24% |
| 2018 Q2 | 54.17 Million CAD | 82.58% |
| 2018 Q1 | 29.67 Million CAD | 54.98% |
| 2017 FY | 55.19 Million CAD | 205.51% |
| 2017 Q4 | 19.14 Million CAD | 18.93% |
| 2017 Q3 | 16.1 Million CAD | 37.61% |
| 2017 Q2 | 11.7 Million CAD | 41.84% |
| 2017 Q1 | 8.24 Million CAD | 38.97% |
| 2016 Q1 | 3.07 Million CAD | 151.75% |
| 2016 Q2 | 3.88 Million CAD | 26.47% |
| 2016 Q3 | 5.17 Million CAD | 33.23% |
| 2016 Q4 | 5.93 Million CAD | 14.69% |
| 2016 FY | 18.06 Million CAD | 1155.29% |
| 2015 Q1 | - CAD | 100.0% |
| 2015 Q3 | 219.23 Thousand CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q4 | 1.22 Million CAD | 456.51% |
| 2015 FY | 1.43 Million CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q4 | -18.5 Thousand CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2009 FY | - CAD | -100.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 Q1 | - CAD | -100.0% |
| 2008 Q4 | 40.83 Thousand CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2008 FY | 40.83 Thousand CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Avicanna Inc. | 16.79 Million CAD | -1509.632% |
| Avant Brands Inc. | 26.34 Million CAD | -925.968% |
| Cardiol Therapeutics Inc. | - CAD | -Infinity% |
| Crescita Therapeutics Inc. | 17.52 Million CAD | -1442.524% |
| Knight Therapeutics Inc. | 328.19 Million CAD | 17.647% |
| MediPharm Labs Corp. | 33.06 Million CAD | -717.497% |
| OrganiGram Holdings Inc. | 149.2 Million CAD | -81.147% |
| Canopy Growth Corporation | 297.14 Million CAD | 9.041% |
| Willow Biosciences Inc. | 1.17 Million CAD | -22961.519% |
| Auxly Cannabis Group Inc. | 101.07 Million CAD | -167.398% |